Carret Asset Management, LLC Abbott Laboratories Transaction History

Carret Asset Management, LLC

$898 Million
Q3 2024

A detailed history of Carret Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Carret Asset Management, LLC holds 50,143 shares of ABT stock, worth $5.75 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

50,143

Previous 50,743 1.18%

Holding current value

$5.75 Million

Previous $5.27 Million 8.42%

% of portfolio

0.64%

Previous 0.63%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $60,041 - $70,878	-600 Reduced 1.18%	50,143 $5.72 Million
Q2 2024 Aug 01, 2024	SELL	$100.73 - $112.44 $20,750 - $23,162	-206 Reduced 0.4%	50,743 $5.27 Million
Q1 2024 Apr 18, 2024	SELL	$109.52 - $120.96 $31,213 - $34,473	-285 Reduced 0.56%	50,949 $5.79 Million
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $2,254 - $2,760	-25 Reduced 0.05%	51,234 $5.64 Million
Q3 2023 Oct 12, 2023	SELL	$95.53 - $114.62 $11,941 - $14,327	-125 Reduced 0.24%	51,259 $4.96 Million
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $51,901 - $57,829	-515 Reduced 0.99%	51,384 $5.6 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $244,571 - $287,875	-2,525 Reduced 4.64%	51,899 $5.26 Million
Q4 2022 Jan 10, 2023	SELL	$95.06 - $111.52 $10,361 - $12,155	-109 Reduced 0.2%	54,424 $5.98 Million
Q3 2022 Oct 11, 2022	BUY	$96.76 - $112.03 $967 - $1,120	10 Added 0.02%	54,533 $5.28 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $58,077 - $70,197	-569 Reduced 1.03%	54,523 $5.92 Million
Q1 2022 Apr 13, 2022	BUY	$114.02 - $139.04 $15,848 - $19,326	139 Added 0.25%	55,092 $6.52 Million
Q4 2021 Jan 10, 2022	BUY	$115.53 - $141.46 $20,217 - $24,755	175 Added 0.32%	54,953 $7.73 Million
Q3 2021 Oct 27, 2021	SELL	$116.66 - $129.06 $59,729 - $66,078	-512 Reduced 0.93%	54,778 $6.47 Million
Q2 2021 Jul 14, 2021	SELL	$105.79 - $124.53 $108,328 - $127,518	-1,024 Reduced 1.82%	55,290 $6.41 Million
Q1 2021 Jul 14, 2021	SELL	$108.84 - $128.23 $37,549 - $44,239	-345 Reduced 0.61%	56,314 $6.75 Million
Q4 2020 Mar 16, 2021	BUY	$105.0 - $114.42 $4,200 - $4,576	40 Added 0.07%	56,659 $6.2 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $262,548 - $318,845	-2,865 Reduced 4.82%	56,619 $6.16 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $13,016 - $16,660	-170 Reduced 0.28%	59,484 $5.44 Million
Q1 2020 May 18, 2020	SELL	$62.82 - $91.86 $86,314 - $126,215	-1,374 Reduced 2.25%	59,654 $4.71 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $12,169 - $13,547	155 Added 0.25%	61,028 $5.3 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $62,034 - $67,264	-758 Reduced 1.23%	60,873 $5.09 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $88,184 - $102,850	-1,210 Reduced 1.93%	61,631 $5.18 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $80,788 - $97,673	-1,220 Reduced 1.9%	62,841 $5.02 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $80,245 - $90,906	-1,224 Reduced 1.87%	64,061 $4.63 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $99,424 - $119,943	-1,635 Reduced 2.44%	65,285 $4.79 Million
Q2 2018 Aug 08, 2018	SELL	$57.57 - $63.54 $23,315 - $25,733	-405 Reduced 0.6%	66,920 $4.08 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $82,154 - $92,885	-1,460 Reduced 2.12%	67,325 $4.03 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $107,360 - $114,940	-2,000 Reduced 2.83%	68,785 $3.93 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $35,564 - $39,693	-740 Reduced 1.03%	70,785 $3.78 Million
Q2 2017 Aug 15, 2017	BUY	N/A	71,525	71,525 $3.48 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carret Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carret Asset Management, LLC with notifications on news.

Account

Carret Asset Management, LLC Abbott Laboratories Transaction History